Novolog and Myoclonus - a phase IV clinical study of FDA data

Summary:

Myoclonus is reported as a side effect among people who take Novolog (insulin aspart recombinant), especially for people who are male, 60+ old, also take Lantus, and have Acute lymphocytic leukaemia recurrent.

The phase IV clinical study analyzes which people have Myoclonus when taking Novolog. It is created by eHealthMe based on reports of 55,653 people who have side effects when taking Novolog from the FDA, and is updated regularly.

What is Novolog?

Novolog has active ingredients of insulin aspart recombinant. It is often used in diabetes. eHealthMe is studying from 56,160 Novolog users. Check the latest studies of Novolog.

What is Myoclonus?

Myoclonus (a brief, involuntary twitching of a muscle or a group of muscles) is found to be associated with 759 drugs and 1,139 conditions by eHealthMe. Check the latest studies of Myoclonus.

On Jul, 08, 2026

55,653 people reported to have side effects when taking Novolog.
Among them, 13 people (0.02%) have Myoclonus.

Among these 13 people:

What is the gender of people who have Myoclonus when taking Novolog? *

female: 46.15 %
male: 53.85 %

What is the age of people who have Myoclonus when taking Novolog? *

What are other drugs people take besides Novolog? *

What are other side effects people have besides Myoclonus? *

Acute Kidney Failure: 5 people, 38.46%
Pneumonia: 5 people, 38.46%
Drowsiness: 5 people, 38.46%
Dyspnea (difficult or laboured breathing): 5 people, 38.46%
Fever: 5 people, 38.46%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 4 people, 30.77%
Anaemia (lack of blood): 4 people, 30.77%
Back Pain: 4 people, 30.77%
Cardiac Arrest: 4 people, 30.77%
Head Injury: 4 people, 30.77%

What are the existing conditions these people have? *

Acute Lymphocytic Leukaemia Recurrent (cancer in which the bone marrow makes too many lymphocytes-recurrent): 3 people, 23.08%
Pain: 2 people, 15.38%
Immune System Disorder: 1 person, 7.69%
Blood Pressure Abnormal: 1 person, 7.69%
Cardiac Disorder: 1 person, 7.69%
Cystic Fibrosis (disease of the secretary glands): 1 person, 7.69%
Diabetic Nephropathy (diabetic kidney disease): 1 person, 7.69%
Diabetic Neuropathy (neuropathic disorders that are associated with diabetes mellitus): 1 person, 7.69%
Hypovitaminosis (any of several diseases caused by deficiency of one or more vitamins): 1 person, 7.69%
Sinus Disorder (disease of sinus): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Novolog and have Myoclonus?

- Check whether Myoclonus is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Novolog:

Novolog (56,160 reports)

Myoclonus treatments and more:

Myoclonus (14,211 reports)

Browse all side effects of Novolog:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Myoclonus:

Myoclonus (759 drugs)

Browse all the conditions that are associated with Myoclonus:

Myoclonus (1,139 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on insulin aspart recombinant (the active ingredients of Novolog) and Novolog (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.